NO20084835L - Culture method for obtaining a clone population of antigen-specific B cells - Google Patents

Culture method for obtaining a clone population of antigen-specific B cells

Info

Publication number
NO20084835L
NO20084835L NO20084835A NO20084835A NO20084835L NO 20084835 L NO20084835 L NO 20084835L NO 20084835 A NO20084835 A NO 20084835A NO 20084835 A NO20084835 A NO 20084835A NO 20084835 L NO20084835 L NO 20084835L
Authority
NO
Norway
Prior art keywords
antigen
cells
obtaining
specific
culture method
Prior art date
Application number
NO20084835A
Other languages
Norwegian (no)
Inventor
John Latham
Leon Garcia
Anne Elisabeth Carvalho Jensen
Ethan Ojala
Original Assignee
Alder Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39283142&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20084835(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alder Biopharmaceuticals Inc filed Critical Alder Biopharmaceuticals Inc
Publication of NO20084835L publication Critical patent/NO20084835L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/248—IL-6
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

Det beskrives fremgangsmåter for isolering av antigenspesifikke celler og fremstilling av antistoffer fra disse.Methods for isolating antigen-specific cells and producing antibodies therefrom are described.

NO20084835A 2006-05-19 2008-11-18 Culture method for obtaining a clone population of antigen-specific B cells NO20084835L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80141206P 2006-05-19 2006-05-19
PCT/US2007/011980 WO2008045140A1 (en) 2006-05-19 2007-05-21 Culture method for obtaining a clonal population of antigen-specific b cells

Publications (1)

Publication Number Publication Date
NO20084835L true NO20084835L (en) 2009-02-16

Family

ID=39283142

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084835A NO20084835L (en) 2006-05-19 2008-11-18 Culture method for obtaining a clone population of antigen-specific B cells

Country Status (12)

Country Link
US (3) US20070269868A1 (en)
EP (1) EP2021463B1 (en)
JP (1) JP5607357B2 (en)
CN (1) CN101600793B (en)
AU (1) AU2007307324B2 (en)
CA (1) CA2652392C (en)
DK (1) DK2021463T3 (en)
IL (1) IL195285A (en)
MX (1) MX2008014692A (en)
NO (1) NO20084835L (en)
NZ (1) NZ572807A (en)
WO (1) WO2008045140A1 (en)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2164514T3 (en) 2007-05-21 2017-02-27 Alderbio Holdings Llc Antibodies to IL-6 and its use
US8404235B2 (en) 2007-05-21 2013-03-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
US8062864B2 (en) 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
US8178101B2 (en) 2007-05-21 2012-05-15 Alderbio Holdings Inc. Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
US7906117B2 (en) 2007-05-21 2011-03-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US8252286B2 (en) 2007-05-21 2012-08-28 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US9452227B2 (en) 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US8420089B2 (en) 2008-11-25 2013-04-16 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8323649B2 (en) 2008-11-25 2012-12-04 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
KR20110112307A (en) * 2008-11-25 2011-10-12 앨더 바이오파마슈티컬즈, 인코포레이티드 IL-6 antagonist that raises albumin and / or lowers Crp
US8337847B2 (en) 2008-11-25 2012-12-25 Alderbio Holdings Llc Methods of treating anemia using anti-IL-6 antibodies
US9079942B2 (en) * 2009-02-09 2015-07-14 Epitomics, Inc. CDR-anchored amplification method
US20100317539A1 (en) * 2009-06-12 2010-12-16 Guo-Liang Yu Library of Engineered-Antibody Producing Cells
KR101790802B1 (en) 2009-09-03 2017-10-27 머크 샤프 앤드 돔 코포레이션 Anti-gitr antibodies
US8293483B2 (en) 2009-09-11 2012-10-23 Epitomics, Inc. Method for identifying lineage-related antibodies
CN102740888B (en) 2009-11-24 2016-10-12 奥尔德生物制药公司 IL-6 antibody and application thereof
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
TWI667257B (en) 2010-03-30 2019-08-01 中外製藥股份有限公司 Antibodies with modified affinity to fcrn that promote antigen clearance
SI2400298T1 (en) 2010-05-28 2013-11-29 F. Hoffmann-La Roche Ag Single B-cell cultivation method and specific antibody production
CA2818813C (en) 2010-11-23 2020-10-06 Alder Biopharmaceuticals, Inc. Anti-il-6 antibodies for the treatment of oral mucositis
EP2646468B1 (en) 2010-12-01 2018-07-25 AlderBio Holdings LLC Anti-ngf compositions and use thereof
JP5963746B2 (en) 2011-03-30 2016-08-03 国立大学法人富山大学 Plasma cell or plasmablast selection method, target antigen-specific antibody production method, novel monoclonal antibody
TWI705825B (en) 2011-05-20 2020-10-01 美商艾爾德生物控股有限責任公司 Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
PE20141787A1 (en) 2011-05-20 2014-12-07 Alderbio Holdings Llc ANTI-CGRP COMPOSITIONS AND USE OF THEM
CN107827982B (en) 2011-05-20 2021-07-06 H.伦德贝克公司 Use of anti-CGRP antibodies and antibody fragments for the prevention or inhibition of photophobia or photophobia in a subject in need thereof
EP2724157B1 (en) * 2011-06-27 2017-03-08 Valneva Method for screening cells
CN109254143A (en) * 2011-09-28 2019-01-22 艾瑞普特公司 Use the adaptive immune response of Arm-PCR and high-flux sequence identification antigen-specific
ES2617488T3 (en) 2011-11-23 2017-06-19 F. Hoffmann-La Roche Ag Mammalian cells expressing CD40L and its use
EP2794652B1 (en) 2011-12-21 2017-11-15 F. Hoffmann-La Roche AG Rapid method for cloning and expression of cognate antibody variable region gene segments
EP2727943A1 (en) 2012-11-05 2014-05-07 MAB Discovery GmbH Trispecific antibodies against human EGFR, HER2 and HER3
EP2727941A1 (en) 2012-11-05 2014-05-07 MAB Discovery GmbH Method for the production of multispecific antibodies
EP2727942A1 (en) 2012-11-05 2014-05-07 MAB Discovery GmbH Bispecific antibodies against human EGFR, HER2, and HER3
EP2914629A1 (en) 2012-11-05 2015-09-09 MAB Discovery GmbH Method for the production of multispecific antibodies
CN104903349B (en) 2012-11-08 2018-10-19 十一生物治疗股份有限公司 IL-6 antagonists and its application
MX2015005862A (en) * 2012-11-13 2015-09-10 Genentech Inc ENRICHMENT OF SPECIFIC ANTIGEN PLASMABLASTOS.
JP2016506974A (en) * 2013-02-15 2016-03-07 エスバテック − ア ノバルティスカンパニー エルエルシー Acceptor framework for CDR grafting
WO2014153166A2 (en) * 2013-03-14 2014-09-25 Alder Biopharmaceuticals, Inc. Therapeutic use of antibodies to hgf
US20160033504A1 (en) * 2013-03-15 2016-02-04 Alder Biopharmaceuticals, Inc. Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigens
TWI670279B (en) 2013-03-15 2019-09-01 Alder Biopharmaceuticals, Inc. Antibody purification and purity monitoring
CA2905180C (en) 2013-03-15 2023-03-07 Alder Biopharmaceuticals, Inc. Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
US20160075766A1 (en) 2013-05-21 2016-03-17 Roche Diagnostics Operations, Inc. Method for producing antibodies using ovine b-cells and uses thereof
CN104232577B (en) * 2013-06-20 2017-12-01 中国人民解放军军事医学科学院基础医学研究所 A kind of method for obtaining autoreactivity B cell
IL243355B2 (en) 2013-07-03 2024-10-01 Lundbeck Seattle Biopharmaceuticals Inc Regulation of glucose metabolism using an anti-CGRP antibody
JP6594438B2 (en) 2014-11-07 2019-10-23 セセン バイオ， インコーポレイテッド Improved IL-6 antibody
EP4691556A3 (en) 2014-12-19 2026-04-29 H. Lundbeck A/S Humanized anti-acth antibodies and use thereof
WO2016149137A1 (en) * 2015-03-18 2016-09-22 Epitomics, Inc. High throughput monoclonal antibody generation by b cell panning and proliferation
US11174317B2 (en) 2015-06-04 2021-11-16 National Center Of Neurology And Psychiatry Therapeutic agent for mental illness comprising IL-6 inhibitor as active ingredient
JP7114460B2 (en) 2015-06-26 2022-08-08 サノフィ・バイオテクノロジー Monoclonal anti-IL-1RAcP antibody
CN108718522A (en) 2016-02-23 2018-10-30 赛森生物股份有限公司 IL-6 antagonist formulations and application thereof
CN108884442B (en) 2016-03-30 2023-06-02 豪夫迈·罗氏有限公司 B cell culture method
KR102444717B1 (en) 2016-04-15 2022-09-16 하. 룬드벡 아크티에셀스카브 Humanized anti-PACAP antibodies and uses thereof
EP3241845A1 (en) 2016-05-06 2017-11-08 MAB Discovery GmbH Humanized anti-il-1r3 antibodies
CN106350485B (en) * 2016-08-24 2020-02-21 杭州百凌生物科技有限公司 A rapid and efficient method for the isolation of single antigen-specific B cells
EP3562936B1 (en) 2017-01-02 2024-05-22 F. Hoffmann-La Roche AG B-cell cultivation method
EP3401332A1 (en) 2017-05-08 2018-11-14 MAB Discovery GmbH Anti-il-1r3 antibodies for use in inflammatory conditions
CN110621773B (en) 2017-05-19 2023-06-09 豪夫迈·罗氏有限公司 Method for producing thymocyte supernatant
US11125757B2 (en) * 2017-05-26 2021-09-21 Emory University Methods of culturing and characterizing antibody secreting cells
WO2019105864A1 (en) 2017-11-30 2019-06-06 F. Hoffmann-La Roche Ag B-cell cultivation method
JP2021525070A (en) * 2018-05-18 2021-09-24 チャン ザッカーバーグ バイオハブ， インコーポレイテッド Methods for Isolating Human-Derived Allergen-Specific Antibodies and Their Use
WO2021014389A1 (en) 2019-07-24 2021-01-28 H. Lundbeck A/S Anti-mglur5 antibodies and uses thereof
JP2023106635A (en) 2020-04-17 2023-08-02 中外製薬株式会社 Bispecific Antigen Binding Molecules and Compositions Associated Therewith, Uses, Kits, and Methods for the Manufacture of Compositions
JPWO2022004620A1 (en) * 2020-06-29 2022-01-06
EP4305190A4 (en) 2021-03-11 2025-03-26 Iggenix, Inc. METHODS AND SYSTEMS FOR PREDICTING AN ALLERGIC RESPONSE
WO2022241415A1 (en) * 2021-05-11 2022-11-17 Yale University Methods for monoclonal antibody generation
AR130550A1 (en) 2022-09-21 2024-12-18 Sanofi Biotechnology HUMANIZED ANTI-IL-1R3 ANTIBODY AND METHODS OF USE

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6657103B1 (en) * 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
AU7796291A (en) * 1990-05-04 1991-11-27 Baxter Diagnostics Inc. High affinity antibodies to small peptides
CA2090126C (en) 1990-08-02 2002-10-22 John W. Schrader Methods for the production of proteins with a desired function
DK0488470T3 (en) * 1990-11-26 1997-12-22 Akzo Nobel Nv Method for producing antibodies
US6277969B1 (en) * 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US5256542A (en) * 1992-03-09 1993-10-26 Tanox Biosystems, Inc. Selecting low frequency antigen-specific single B lymphocytes with correction for background noise
US6972125B2 (en) * 1999-02-12 2005-12-06 Genetics Institute, Llc Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
PT2308888T (en) * 2001-11-14 2017-05-03 Janssen Biotech Inc Anti-il-6 antibodies, compositions, methods and uses
US20040185040A1 (en) * 2001-11-21 2004-09-23 Celltech R & D Limited Modulating immune responses
US8188231B2 (en) * 2002-09-27 2012-05-29 Xencor, Inc. Optimized FC variants
ES2374068T3 (en) 2002-12-03 2012-02-13 Ucb Pharma, S.A. TEST TO IDENTIFY ANTIBODY PRODUCTION CELLS.
GB0312481D0 (en) 2003-05-30 2003-07-09 Celltech R&D Ltd Antibodies
AU2003259718A1 (en) * 2003-08-07 2005-03-07 Epitomics, Inc. Methods for humanizing rabbit monoclonal antibodies
US7771969B2 (en) 2003-08-20 2010-08-10 Celltech R&D Limited Methods for obtaining antibodies
ES2385829T3 (en) 2003-08-20 2012-08-01 Ucb Pharma, S.A. Methods to obtain antibodies
AU2004266159A1 (en) * 2003-08-22 2005-03-03 Biogen Idec Ma Inc. Improved antibodies having altered effector function and methods for making the same
US9128090B2 (en) * 2003-08-29 2015-09-08 Janssen Biotech, Inc. Rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method
CA2541651C (en) * 2003-10-22 2011-05-24 Keck Graduate Institute Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
GB0412973D0 (en) 2004-06-10 2004-07-14 Celltech R&D Ltd Identification of antibody producing cells
US20060051348A1 (en) * 2004-09-09 2006-03-09 Jorn Gorlach Method of producing a plurality of isolated antibodies to a plurality of cognate antigens
CN101048426A (en) * 2004-10-22 2007-10-03 金克克国际有限公司 Isolating human antibodies
US7462697B2 (en) * 2004-11-08 2008-12-09 Epitomics, Inc. Methods for antibody engineering
GB0425972D0 (en) 2004-11-25 2004-12-29 Celltech R&D Ltd Biological products
JO3058B1 (en) * 2005-04-29 2017-03-15 Applied Molecular Evolution Inc Anti-IL-6 Antibodies,Compositions,Methods and uses
US20070092943A1 (en) * 2005-09-28 2007-04-26 The University Of Chicago Versatile vectors for expression of foreign proteins in photosynthetic bacteria

Also Published As

Publication number Publication date
CN101600793A (en) 2009-12-09
IL195285A0 (en) 2011-08-01
IL195285A (en) 2012-07-31
WO2008045140A1 (en) 2008-04-17
DK2021463T3 (en) 2017-01-16
EP2021463B1 (en) 2016-11-23
AU2007307324B2 (en) 2013-08-15
US20070269868A1 (en) 2007-11-22
CA2652392C (en) 2017-10-10
US20130316353A1 (en) 2013-11-28
EP2021463A1 (en) 2009-02-11
EP2021463A4 (en) 2009-09-02
CN101600793B (en) 2013-06-26
JP5607357B2 (en) 2014-10-15
AU2007307324A1 (en) 2008-04-17
JP2009537176A (en) 2009-10-29
US20120141982A1 (en) 2012-06-07
CA2652392A1 (en) 2008-04-17
NZ572807A (en) 2011-10-28
MX2008014692A (en) 2009-08-18

Similar Documents

Publication Publication Date Title
NO20084835L (en) Culture method for obtaining a clone population of antigen-specific B cells
AU2019268194A1 (en) Cell culture system
MX2008011838A (en) Propagation of primary cells.
WO2008002914A3 (en) Method of culturing mesenchymal stem cells
EP1910513A4 (en) METHODS FOR ISOLATING CELLS AND GENERATING MONOCLONAL ANTIBODIES
NO20071309L (en) Method of expansion
NZ595786A (en) Placental stem cell populations
EP1773383A4 (en) Antibodies as t cell receptor mimics, methods of production and uses thereof
ZA200703124B (en) System and method for production of antibodies in plant cell culture
WO2008024769A3 (en) Intensified perfusion production method
DK2030476T3 (en) Method and system for improving the intelligibility of sounds
WO2010006055A3 (en) Improved gas permeable cell culture device and method of use
DK1623017T3 (en) Generation and isolation of antigen-specific T cells
EP2343361A4 (en) CELL CULTURE KIT, SCREENING METHOD, AND METHOD FOR MANUFACTURING THE CELL CULTURE KIT
WO2010020876A3 (en) Cell culture method to form aggregates
DK1974017T4 (en) Means and methods for affecting the stability of antibody producing cells
WO2012019002A3 (en) Somatic stem cells
WO2006136953A3 (en) Method of producing organotypic cell cultures
EA200800996A1 (en) METHOD OF OBTAINING T-CELL POPULATION
WO2007017915A3 (en) Use of common ϝ chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes.
EP1941275A4 (en) Method of identifying membrane lg specific antibodies and use thereof for targeting immunoglobulin-producing precursor cells
MX2010003027A (en) Plant stem cell line derived from quiescent center and method for isolating the same.
EP1765983A4 (en) METHODS AND COMPOSITIONS FOR THE PRODUCTION OF STEM CELLS FROM GERMINAL STEM CELLS DERIVED FROM SPINAL CORD
ATE546524T1 (en) METHOD FOR PRODUCING ACTIVE SCFV ANTIBODIES AND LIBRARIES THEREOF
EP2021464A4 (en) METHOD FOR CULTURING HUMAN EMBRYOONAL STEM CELLS